Jiangsu vs Guangdong: why the battle to be China’s No 1 economy is heating up
The southern Guangdong province has been the largest engine powering China’s economic rise for decades. But the region…
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve…
Yokogawa and Repligen partner to enhance process analytical technology
Yokogawa Corporation of America and Repligen announce a collaboration to integrate Yokogawa’s OpreX Bio Pilot with Repligen’s MAVERICK®,…
Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics
Labman is proud to be involved in a groundbreaking Canada-UK collaboration to revolutionize biopharmaceutical manufacturing using cutting-edge automation,…